With regard to molecular features, several studies found that both EGFR mutations and ALK rearrangements were less prevalent in COPD-associated lung cancer [73, 74], and the presence of EGFR mutations was inversely correlated with the severity of airflow limitation [73]. This evidence concerns the gene EGFR and lung cancer.